{
    "name": "levobunolol",
    "comment": "Rx",
    "other_names": [
        "Betagan",
        "AKBeta"
    ],
    "classes": [
        "Antiglaucoma",
        "Beta-Blockers"
    ],
    "source": "https://reference.medscape.com/drug/betagan-akbeta-levobunolol-343597",
    "pregnancy": {
        "common": [
            "There are no adequate and well-controlled studies in pregnant women; ophthalmic solution should be used during pregnancy only if potential benefit justifies potential risk to fetus"
        ],
        "specific": []
    },
    "lactation": {
        "common": [
            "It is not known whether drug is excreted in human milk; systemic beta-blockers and topical timolol maleate are known to be excreted in human milk; exercise caution when administered to a nursing woman"
        ]
    },
    "warnings": {
        "black_box_warning": {
            "common": [],
            "specific": []
        },
        "contraindicators": {
            "common": [
                "Asthma, uncompensated CHF, any beta-blocker side effects, COPD, sinus bradycardia, 2°/3° AV block, hypersensitivity",
                "Cardiogenic shock or with overt cardiac failure not adequately compensated (eg, treated with cardiac glycosides &/or diuretics)"
            ],
            "specific": []
        },
        "cautions": {
            "common": [
                "Caution on inadequate cardiac function, latent cardiac insufficiency, cerebrovascular insufficiency, sick sinus syndrome, peripheral vascular disease, history of psychiatric illness, heart failure, diminished pulmonary function, nonallergic bronchospasm, diabetes mellitus, myasthenia gravis",
                "Ophthalmic beta-blockers may impair compensatory tachycardia and increase risk of hypotension",
                "Patients receiving topical levobunolol & a systemic ß-adrenergic blocking agent concomitantly should be observed carefully for potential additive effects on IOP &/or systemic effects of ß-adrenergic blockade",
                "May mask signs of hyperthyroidism (ie, tachycardia)",
                "May potentiate syndromes associated with vascular insufficiency (i.e. Raynaud’s phenomenon); use with caution",
                "Choroidal detachment after filtration procedures reported with administration of aqueous suppressant therapy",
                "Preservative benzalkonium chloride may be absorbed by soft contact lenses; patients wearing soft (hydrophilic) contact lenses should be instructed to remove contact lenses before administration of the solution and wait at least 15 minutes after instilling therapy before reinserting soft contact lenses",
                "Use with a miotic in angle-closure glaucoma"
            ],
            "specific": []
        }
    },
    "interactions": [],
    "adverse effects": [
        {
            "name": "Mild ocular stinging",
            "percent": null
        },
        {
            "name": "Ataxia",
            "percent": null
        },
        {
            "name": "Burning",
            "percent": null
        },
        {
            "name": "Lethargy",
            "percent": null
        },
        {
            "name": "Discomfort",
            "percent": null
        },
        {
            "name": "Band keratopathy",
            "percent": null
        },
        {
            "name": "Respiratory failure",
            "percent": null
        },
        {
            "name": "Blepharitis",
            "percent": null
        },
        {
            "name": "Impotence",
            "percent": null
        },
        {
            "name": "Blepharoconjunctivitis",
            "percent": null
        },
        {
            "name": "Conjunctivitis",
            "percent": null
        },
        {
            "name": "Decreased visual acuity",
            "percent": null
        },
        {
            "name": "Erythema",
            "percent": null
        },
        {
            "name": "Iridocyclitis",
            "percent": null
        },
        {
            "name": "Itching sensation",
            "percent": null
        },
        {
            "name": "Decreased corneal sensitivity",
            "percent": null
        },
        {
            "name": "Tearing",
            "percent": null
        },
        {
            "name": "Urticaria",
            "percent": null
        },
        {
            "name": "Paresthesia",
            "percent": null
        },
        {
            "name": "Ptosis",
            "percent": null
        },
        {
            "name": "Cerebral ischemia",
            "percent": null
        },
        {
            "name": "Decreased blood pressure",
            "percent": null
        },
        {
            "name": "Hypersensitivity reactions",
            "percent": null
        },
        {
            "name": "Heart block",
            "percent": null
        },
        {
            "name": "Syncope",
            "percent": null
        },
        {
            "name": "Reduction of resting heart rate",
            "percent": null
        },
        {
            "name": "Special senses",
            "percent": null
        },
        {
            "name": "Signs and symptoms of keratitis or eye allergy",
            "percent": null
        },
        {
            "name": "blepharoptosis",
            "percent": null
        },
        {
            "name": "visual disturbances including refractive changes",
            "percent": null
        },
        {
            "name": "due to withdrawal of miotic therapy in some cases",
            "percent": null
        },
        {
            "name": "diplopia",
            "percent": null
        },
        {
            "name": "and foreign body sensation in eye",
            "percent": null
        }
    ]
}